Global Nucleic Acid Drugs Market Insights, Forecast to 2029
상품코드:1373465
리서치사:QYResearch
발행일:2023년 11월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 핵산 의약품 시장 규모는 2023년 124억 8,673만 달러에서 예측기간 동안 3.71%의 CAGR로 성장하여 2029년에는 155억 3,836만 달러 규모로 성장할 것으로 예측됩니다.
지역별로는 미국·캐나다 시장은 2023년 43억 5,770만 달러에서 10.46%의 CAGR로 성장하여 2029년에는 79억 1,760만 달러에 달할 것으로 예측됩니다. 한편 유럽 시장은 2023년 55억 7,025만 달러에서 -4.24%의 CAGR로 성장하여 2029년에는 42억 9,509만 달러에 달할 것으로 예측됩니다.
세계 상위 5개사에 의한 2022년 매출 점유율은 약 97.87%에 달했습니다.
세계의 핵산 의약품 시장을 조사했으며, 시장 및 제품 개요, 경쟁 상황, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 상세 분석, 가격 동향, 시장 성장에 대한 각종 영향요인 분석, 주요 기업 분석 등을 정리했습니다.
목차
제1장 보고서 개요
조사 범위
유형별 시장 분석
성장률 : 2018 vs 2022 vs 2029
안티센스 올리고뉴클레오티드(ASO) 의약품
저분자 간섭 RNA(siRNA) 의약품
mRNA 의약품
용도별 시장
시장 점유율 : 2018 vs 2022 vs 2029
신경근질환
hATTR
COVID-19
가정·제한
조사 목적
조사 기간
제2장 세계의 성장 동향
세계 시장 전망
세계의 성장 동향 : 지역별
시장 규모 : 2018 vs 2022 vs 2029
시장 규모 추정
시장 규모 예측
시장 역학
산업 동향
시장 성장 촉진요인
시장 과제
시장 성장 억제요인
제3장 경쟁 상황 : 주요 기업별
매출·매출 점유율 : 주요 기업별
세계의 주요 기업 : 기업 유형별
세계 주요 기업의 매출 순위
시장 집중률(CR5)
세계의 주요 기업 : 본사 및 서비스 제공 지역
세계의 주요 기업 : 제품·용도
세계의 주요 기업 : 설립일
M&A·확장 계획
제4장 핵산 의약품 시장 내역 데이터 : 유형별
시장 규모 추정과 예측
제5장 핵산 의약품 시장 내역 데이터 : 용도별
시장 규모 추정과 예측
제6장 북미
제7장 유럽
제8장 중국
제9장 아시아(중국 제외)
제10장 중동, 아프리카 및 라틴아메리카
제11장 주요 기업 개요
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
제12장 애널리스트에 의한 견해·결론
제13장 부록
KSM
영문 목차
영문목차
The global Nucleic Acid Drugs market size is projected to reach US$ 15538.36 million by 2029, from US$ 12486.73 million in 2023, at a CAGR of 3.71% during 2023-2029
The US & Canada market for Nucleic Acid Drugs is estimated to increase from $ 4357.7 million in 2023 to reach $ 7917.6 million by 2029, at a CAGR of 10.46% during the forecast period of 2023 through 2029.
The Europe market for Nucleic Acid Drugs is estimated to increase from $ 5570.25 million in 2023 to reach $ 4295.09million by 2029, at a CAGR of -4.24% during the forecast period of 2023 through 2029.
The global key companies of Nucleic Acid Drugs include: Pfizer, Moderna Therapeutics, BioNTech, Biogen, Alnylam, Sarepta Therapeutics, Jazz Pharmaceuticals, Nippon Shinyaku, Novartis, Sobi, Ionis Pharmaceuticals, etc. In 2022, the global top five players had a share approximately 97.87% in terms of revenue.
Report Includes:
This report presents an overview of global market for Nucleic Acid Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Nucleic Acid Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nucleic Acid Drugsrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Nucleic Acid Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Nucleic Acid Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, BioNTech, Nippon Shinyaku, Moderna Therapeutics, CureVac, and Biogen, etc.
By Company
On Market Company
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
On Pipeline Company
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Segment by Type
Antisense Oligonucleotides (ASOs) Drugs
Small Interfering RNA (siRNA) Drugs
mRNA Drugs
Others
Segment by Application
Neuromuscular Diseases
hATTR
COVID-19
Other
By Region
North America
United States
Canada
China
Asia-Pacific
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Rest of Latin America
Middle East
Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Nucleic Acid Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Drugs companies's competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Drugsrevenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antisense Oligonucleotides (ASOs) Drugs
1.2.3 Small Interfering RNA (siRNA) Drugs
1.2.4 mRNA Drugs
1.3 Market by Application
1.3.1 Global Nucleic Acid Drugs Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Neuromuscular Diseases
1.3.3 hATTR
1.3.4 COVID-19
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Drugs Market Perspective (2018-2029)
2.2 Global Nucleic Acid Drugs Growth Trends by Region
2.2.1 Global Nucleic Acid Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nucleic Acid Drugs Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid Drugs Forecasted Market Size by Region (2024-2029)
2.3 Nucleic Acid Drugs Market Dynamics
2.3.1 Nucleic Acid Drugs Industry Trends
2.3.2 Nucleic Acid Drugs Market Drivers
2.3.3 Nucleic Acid Drugs Market Challenges
2.3.4 Nucleic Acid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nucleic Acid Drugs by Players
3.1.1 Global Nucleic Acid Drugs Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nucleic Acid Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Nucleic Acid Drugs Market Concentration Ratio
3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 5 Companies by Nucleic Acid Drugs Revenue in 2022
3.5 Global Key Players of Nucleic Acid Drugs Head office and Area Served
3.6 Global Key Players of Nucleic Acid Drugs, Product and Application
3.7 Global Key Players Established Date
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Drugs Breakdown Data by Type
4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2029)
5 Nucleic Acid Drugs Breakdown Data by Application
5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nucleic Acid Drugs Market Size (2018-2029)
6.2 North America Nucleic Acid Drugs Market Size by Type
6.2.1 North America Nucleic Acid Drugs Market Size by Type (2018-2023)
6.2.2 North America Nucleic Acid Drugs Market Size by Type (2024-2029)
6.2.3 North America Nucleic Acid Drugs Market Share by Type (2018-2029)
6.3 North America Nucleic Acid Drugs Market Size by Application
6.3.1 North America Nucleic Acid Drugs Market Size by Application (2018-2023)
6.3.2 North America Nucleic Acid Drugs Market Size by Application (2024-2029)
6.3.3 North America Nucleic Acid Drugs Market Share by Application (2018-2029)
6.4 North America Nucleic Acid Drugs Market Size by Country
6.4.1 North America Nucleic Acid Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Nucleic Acid Drugs Market Size by Country (2018-2023)
6.4.3 North America Nucleic Acid Drugs Market Share by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Nucleic Acid Drugs Market Size (2018-2029)
7.2 Europe Nucleic Acid Drugs Market Size by Type
7.2.1 Europe Nucleic Acid Drugs Market Size by Type (2018-2023)
7.2.2 Europe Nucleic Acid Drugs Market Size by Type (2024-2029)
7.2.3 Europe Nucleic Acid Drugs Market Share by Type (2018-2029)
7.3 Europe Nucleic Acid Drugs Market Size by Application
7.3.1 Europe Nucleic Acid Drugs Market Size by Application (2018-2023)
7.3.2 Europe Nucleic Acid Drugs Market Size by Application (2024-2029)
7.3.3 Europe Nucleic Acid Drugs Market Share by Application (2018-2029)
7.4 Europe Nucleic Acid Drugs Market Size by Country
7.4.1 Europe Nucleic Acid Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Nucleic Acid Drugs Market Size by Country (2018-2023)
7.4.3 Europe Nucleic Acid Drugs Market Size by Country (2024-2029)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Nucleic Acid Drugs Market Size (2018-2029)
8.2 China Nucleic Acid Drugs Market Size by Type
8.2.1 China Nucleic Acid Drugs Market Size by Type (2018-2023)
8.2.2 China Nucleic Acid Drugs Market Size by Type (2024-2029)
8.2.3 China Nucleic Acid Drugs Market Share by Type (2018-2029)
8.3 China Nucleic Acid Drugs Market Size by Application
8.3.1 China Nucleic Acid Drugs Market Size by Application (2018-2023)
8.3.2 China Nucleic Acid Drugs Market Size by Application (2024-2029)
8.3.3 China Nucleic Acid Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Nucleic Acid Drugs Market Size (2018-2029)
9.2 Asia Nucleic Acid Drugs Market Size by Type
9.2.1 Asia Nucleic Acid Drugs Market Size by Type (2018-2023)
9.2.2 Asia Nucleic Acid Drugs Market Size by Type (2024-2029)
9.2.3 Asia Nucleic Acid Drugs Market Share by Type (2018-2029)
9.3 Asia Nucleic Acid Drugs Market Size by Application
9.3.1 Asia Nucleic Acid Drugs Market Size by Application (2018-2023)
9.3.2 Asia Nucleic Acid Drugs Market Size by Application (2024-2029)
9.3.3 Asia Nucleic Acid Drugs Market Share by Application (2018-2029)
9.4 Asia Nucleic Acid Drugs Market Size by Region
9.4.1 Asia Nucleic Acid Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Nucleic Acid Drugs Market Size by Region (2018-2023)
9.4.3 Asia Nucleic Acid Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2024-2029)
